OPTI.L实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:04):
Our systems believe the stock currently is undervalued by 0.04% compare to its pairs and should correct upwards.

Stats
今日成交量	126 115
平均成交量	150 758
市值	15.65M
EPS	£-0.00210 ( Q4 \| 2023-12-31 )
下一个收益日期	( £0 ) 2024-09-25
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-7.70 (Sector) 0 (Industry) 0
ATR14	£0.306 (1.99%)

AMYT.L -11.73%

APH.L 0.51%

AVCT.L 1.18%

AZN.L -0.24%

BMK.L 7.59%

BVXP.L -2.16%

C4XD.L 27.32%

CIR.L 0.00%

CLIN.L 0.11%

DEST.L -2.51%

DPH.L 0.05%

EAH.L 2.40%

ERGO.L 0.15%

ETX.L -6.74%

EVG.L 2.25%

FAB.L -1.59%

FARN.L -5.08%

FUM.L 1.58%

GDR.L 3.03%

GNS.L 1.45%

GSK.L -0.52%

HCM.L -0.36%

HEMO.L 0.53%

HIK.L -0.79%

IMM.L -1.15%

INDV.L 0.08%

IXI.L -5.25%

MTPH.L 1 794.74%

MXCT.L -2.17%

N4P.L -4.71%

NCYT.L -2.48%

NFX.L -4.71%

OBD.L 0.92%

OKYO.L -24.32%

ONC.L 0.45%

OPTI.L -3.75%

OVB.L -15.56%

OXB.L 2.58%

PRM.L -4.82%

PRTC.L 1.54%

PYC.L -6.25%

REDX.L 31.58%

RENE.L -2.17%

SAR.L 6.89%

SCLP.L -1.81%

SLN.L -0.93%

SNG.L 3.48%

STX.L 2.70%

TILS.L 8.33%

TRX.L -1.15%

VAL.L 0.00%

VEC.L 0.00%

相关性 (AI algo v.1.1b): Undervalued: 0.04% £15.41 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

OptiBiotix Health PLC 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

OptiBiotix Health PLC 财务报表

Annual	2023
营收:	£644 000
毛利润:	£320 000 (49.69 %)
EPS:	£-0.0226

FY	2023
营收:	£644 000
毛利润:	£320 000 (49.69 %)
EPS:	£-0.0226

FY	2022
营收:	£457 000
毛利润:	£244 000 (53.39 %)
EPS:	£0.0293

FY	2021
营收:	£2.21M
毛利润:	£1.12M (50.76 %)
EPS:	£0.0718

Financial Reports:

No articles found.

OptiBiotix Health PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

OptiBiotix Health PLC

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.